ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PSG Phosphagen.

2.25
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Phosphagen. LSE:PSG London Ordinary Share AU000000POH7 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.25 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Phosphagen. Share Discussion Threads

Showing 176 to 198 of 750 messages
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
20/3/2006
17:14
what????????????!!!!!!!!!!!!!
rambutan2
20/3/2006
16:06
Flint,

I too was overcome by its lack of succinctness.

spaceparallax
20/3/2006
14:14
Cripes - that is a long read...didnt make too much of it unfortunately
flintsurfer
14/3/2006
10:55
We're due some news here surely. About to go away for 3 weeks. I bet it all happens when I'm not here....... : )
worc0670
10/3/2006
02:02
hi suesean,

i dont hold een, but do share an interest in syria via its partner, gpx.

yes, whole bio climate is looking good for psg's prospects and im happy to sit. another one of mine, ymba, which is also a bio, has suddenly sprung into life after a few years of little on the share price front. as you say, psg's day will come.

rambutan2
10/3/2006
01:43
rambutan2

Thanks for the post on een. Still hold psg, bottom draw,our day will come.

suesean1
01/3/2006
23:38
i find the trading in this one odd. so many sells. is someone arbing from oz?

if does get a mention then can spike up nicely, but will no doubt once more be pulled back down by those sells, if they continue.

wonder what the cs view is? they look a bit silly putting out such a bullish note and seeing the price fall to under half their target.

ho hum.

rambutan2
01/3/2006
20:45
tick up today due to mention in shares mag?
only speculating.

lgw
25/2/2006
00:16
finals were issued on 28/02 last year - could certainly do with a bit of a booster/publicity. that said, the current level offers nice chance to buy in/top up at not much above recent 10p placing price. one day this will come out of sleeper mode...
rambutan2
15/2/2006
11:35
currently just under 10p to buy in oz - don't really see why should have to pay such a premium to buy on aim!
rambutan2
31/1/2006
00:07
Me too - risk reward ratio is fantastic for psg. Would be nice for it to pay off sometime soon with some decent rises. Absolutely willing to be patient but I've been holding for some time now, well, about one year.....

If the buy price goes anywhere near 11p I'll be adding some more.

What other stocks are you guys in? I'm in SCR, SOV and ZBA (currently suspended).

I've been looking at AGY but not sure about the competition they're facing.....

cheers

worc0670
30/1/2006
23:56
yes. nothing i didnt know about but greater detail than other reports. what ive always liked about psg is the spread of possibilities that their portfolio offers. shorter term, the best bet is prob good news coming from alza (jnj). longer term, well there's just too many to choose from!
rambutan2
30/1/2006
23:34
rambutan2
did you manage to read the 28 pages ?
looks good 3-6 months so tuck them away imo

lgw
30/1/2006
14:14
many thanks for that lgw, you're a star.
rambutan2
27/1/2006
21:07
copied fromlonger report above for those who cant be bothered to read

News Flow Outlook 2006
Functional foods licensing deal
Clinical data from human trials of Ester E
Initiation of Phase II clinical trials for TPM-01/Morphine
Initiation of human trials for TPM-01/Insulin
Partner signed for development of TPM-01/Morphine / Pain Portfolio
Preclinical data from plaque reduction studies with APA-01
Launch of Phospha E as a dietary supplement in Australia
Initiation of full clinical development programme from ALZA collaboration
Clinical data from Phase II trials for TPM-01/Morphine
QLT acquired Atrix Laboratories
for $855m in stock and cash
Cephalon acquired CIMA
Labs for $515m in cash
ALZA (JnJ) could be a potential
acquirer of PSG's drug delivery
and drug enhancement platforms

lgw
27/1/2006
20:52
remaining pages from my previous post
lgw
27/1/2006
20:32
Warning extremely long post
28 pages which I will delete from this post this sunday night.




.

lgw
27/1/2006
10:22
and the other half?

lgw, could you give us a few tasty sentences, or rev projections or anything to chew on over the weekend?

rambutan2
27/1/2006
09:32
read half of the Collins Stewart note, excellent stuff.
lgw
24/1/2006
02:34
Animal experiments to start on their anti platelet drug (released to Aussie Market 24TH Jan)
cmp - hope all is well - I`ll be watching you Focker

flintsurfer
23/1/2006
14:56
so with all this - why are shares being marked down every day....
jaydeee
22/1/2006
16:33
BBY has come up with the same valuation then 30p per share, albeit this was in November before recent news.
lgw
21/1/2006
12:56
Haven't seen Collins stewart but the Aussie broker's report is on the website...
worc0670
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older

Your Recent History

Delayed Upgrade Clock